Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Chromatography
|
July 12, 1985
Determination of cotinine in biological fluids by capillary gas chromatography-mass spectrometry-selected-ion monitoring
P Daenens, L Laruelle, K Callewaert, et al.
British Journal of Clinical Pharmacology
|
April 1, 1988
Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man
J Arnout, A van Hecken, I De Lepeleire, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
February 10, 2000
Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration
A Dallob, I De Lepeleire, A Van Hecken, et al.
Clinical Pharmacology and Therapeutics
|
March 30, 1999
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
E W Ehrich, A Dallob, I De Lepeleire, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Chromatography
|
July 12, 1985
Determination of cotinine in biological fluids by capillary gas chromatography-mass spectrometry-selected-ion monitoring
P Daenens, L Laruelle, K Callewaert, et al.
British Journal of Clinical Pharmacology
|
April 1, 1988
Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man
J Arnout, A van Hecken, I De Lepeleire, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
February 10, 2000
Ex vivo assays demonstrate potency and selectivity of the COX-2 inhibitor DFP after single dose administration
A Dallob, I De Lepeleire, A Van Hecken, et al.
Clinical Pharmacology and Therapeutics
|
March 30, 1999
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
E W Ehrich, A Dallob, I De Lepeleire, et al.
Page
of 2